BioXcel Therapeutics Inc. (BTAI)
3.81
1.65 (76.39%)
At close: Mar 03, 2025, 3:59 PM
3.43
-9.97%
After-hours: Mar 03, 2025, 07:59 PM EST
BioXcel Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 65.22M | 193.72M | 232.97M | 213.12M | 32.43M | 42.56M | 887K | n/a |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 87K | 925K | 3.93M | 87K | 51K | 51K | 461K | n/a |
| Receivables | 71K | 248K | n/a | n/a | n/a | 115K | n/a | n/a |
| Inventory | 1.99M | 1.99M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 4.86M | 6.91M | 3.84M | 6.91M | 1.68M | 491K | 3K | 2K |
| Total Current Assets | 72.14M | 202.87M | 232.97M | 217.06M | 34.11M | 43.17M | 890K | 2K |
| Property-Plant & Equipment | 1.47M | 2.06M | 2.54M | 2.78M | 2.23M | 327K | 4K | 5K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 1.56M | 2.98M | 6.47M | 2.87M | 2.29M | 378K | 465K | 5K |
| Total Assets | 73.7M | 205.85M | 239.44M | 219.94M | 36.39M | 43.55M | 1.35M | 7K |
| Account Payables | 13.65M | 10.23M | 4.68M | 3.98M | 4.95M | 1.6M | 444K | 279K |
| Deferred Revenue | n/a | n/a | n/a | 7.39M | -164K | n/a | n/a | n/a |
| Short-Term Debt | 346K | 319K | 293K | 237K | n/a | n/a | 371K | n/a |
| Other Current Liabilities | 13.15M | 22.27M | 11.39M | 6.93M | 3.52M | 3.06M | 1.52M | 52K |
| Total Current Liabilities | 27.27M | 32.9M | 16.67M | 11.84M | 8.47M | 4.66M | 2.34M | 331K |
| Long-Term Debt | 101.04M | 94.62M | 2.21M | 2.8M | 1.03M | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.91M | 1.56M | -1.1M | -1.4M | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 102.94M | 96.18M | 1.1M | 1.4M | 1.03M | n/a | n/a | n/a |
| Total Liabilities | 130.21M | 129.08M | 17.77M | 13.24M | 9.5M | 4.66M | 2.34M | 331K |
| Total Debt | 101.38M | 94.16M | 1.4M | 1.64M | 1.03M | n/a | 371K | n/a |
| Common Stock | 30K | 28K | 28K | 24K | 18K | 16K | 10K | n/a |
| Retained Earnings | -590.6M | -411.55M | -245.79M | -138.86M | -56.69M | -23.72M | -4.45M | n/a |
| Comprehensive Income | n/a | 0.00 | n/a | n/a | n/a | -18K | -1K | n/a |
| Shareholders Equity | -56.51M | 76.78M | 221.67M | 206.7M | 26.89M | 38.89M | -982K | -324K |
| Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |